When you offer your patients the freedom to test their INR at home with the CoaguChek INR monitoring device, you can help ensure their success by working with CoaguChek Patient Services. Think of us as your partner in implementing a patient self-testing program that meets your needs to provide clinical care. The CoaguChek Vantus system and CoaguChek Patient Services provide a dependable and patient-centric experience, both for your anticoagulation patients and your clinic, ultimately enhancing patient care.
As your partner, we’re committed to supporting your patient self-testing program so that it runs effectively and efficiently. We handle the administrative tasks associated with enrolling your patients in the INR self-testing program and offer 24/7 dedicated product support for patients, physicians and clinics.
From patient education and insurance verification to testing reminders for patients, we have the structure and resources to maximize patient engagement and support a successful experience for your patients and you.
Verbatim comment from SMARI - CoaguChek HCP Survey (2016). Roche Data on file.
We offer helpful information and resources on INR self-testing for you and your patients
When patients are considering INR self-testing, you’ll want to work with them to ensure that it’s a good fit for their needs and lifestyle. INR self-testing might be a good option for any patient who:
Once you determine that your patient is a candidate for self-testing, our Get Started Guide makes it easy to enroll.
Convenience is at the heart of self-testing with CoaguChek Patient Services. That’s why we offer your patients multiple ways to report their results, including:
When patients are considering PT/INR self-testing, they’re going to have a lot of questions. To help you provide answers, we have a resource library of easy-to-understand, shareable information sources, including these handy downloads and informational videos:
1. Meyer S, Frei CR, Daniels KR, Forcade NA, Bussey M, et al. Impact of a new method of warfarin management on patient satisfaction, time, and cost. Pharmacotherapy 2013: 33(11):1147-55
2. The presence of anti-phospholipid antibodies (APAs) such as Lupus antibodies (LA) can potentially lead to prolonged clotting times, i.e., elevated INR values. A comparison to an APA-insensitive laboratory method is recommended if the presence of APAs is known or suspected. See CoaguChek XS PT Package insert for additional details.
3. Bluetooth connectivity requires a smartphone or tablet. Minimum specifications required. Call 1-800-780-0675 for a list of supported devices and operating systems.